|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
Healthcare Company News 
Zynx Health, Inc. Zynx Health Launches Zynx OncologyCare
Zynx Health, Inc. Zynx Health Launches Zynx OncologyCare
Zynx Health Launches Zynx OncologyCare
Tuesday, 21 April 2009 07:05 | 
| Company News - Zynx Health, Inc. |
Zynx Health Launches Zynx OncologyCare, Providing Evidence-Based Chemotherapy Order Sets Developed with the National Comprehensive Cancer Network
Zynx Health, the leader in evidence-based healthcare, announces the official launch of Zynx OncologyCare, which offers a comprehensive library of actionable order sets developed through a collaboration with the National Comprehensive Cancer Network (NCCN). The order sets are based on the NCCN Chemotherapy Order Templates™ and are consistent with the NCCN Clinical Practice Guidelines in Oncology and the NCCN Drugs & Biologics Compendium.
“We are thrilled to announce the release of Zynx OncologyCare, a product that we’ve developed in collaboration with NCCN,” said Victor Lee, MD, director of content development at Zynx Health. “We believe that Zynx OncologyCare chemotherapy order sets will enable oncology practices to streamline order entry workflow and optimize reimbursement potential.” Zynx OncologyCare order sets are based on the NCCN Drugs & Biologics Compendium, which several major payers regard as a primary source for making cancer coverage determinations. By relying on Zynx OncologyCare order sets, clients can be confident about reimbursement.
Zynx OncologyCare directly addresses the complexities of appropriate chemotherapy administration, including:
• Chemotherapy dosing
• Supportive care, such as premedications and antiemetic therapy
• Monitoring and hold parameters, with applicable laboratory orders
• Safety parameters and special instructions
Clients can access the order sets using Zynx’s Web-based software, AuthorSpace™. AuthorSpace streamlines the content management process by enabling clients to access, customize, share, and update order sets. Cancer centers can then deploy the order sets at the point of care, either in paper form or on an intranet, or to an electronic medical record (EMR) system.
“The NCCN Chemotherapy Order Templates, which are the basis for Zynx OncologyCare, can enhance patient safety by helping clinicians standardize patient care, reduce medication errors, and anticipate and manage adverse events,” said William T. McGivney, PhD, chief executive officer of NCCN. “NCCN is pleased to collaborate with Zynx Health on this new product that promotes the safe use of drugs and biologics in cancer care.”
About Zynx Health
Zynx Health was founded in 1996 by thought leaders in evidence-based healthcare and healthcare quality improvement. Acquired by Hearst Corporation in 2004, Zynx has grown to become a recognized leader in evidence-based clinical decision support and offers a suite of online solutions that help clinicians treat their patients based on the best available evidence from systematic research. The Zynx team of physicians, nurses, and allied health professionals rigorously reviews the latest peer-reviewed literature to develop clinically relevant summaries and distill evidence-based best practices. For more information about Zynx Health, visit www.zynxhealth.com
Source: Zynx Health
“We are thrilled to announce the release of Zynx OncologyCare, a product that we’ve developed in collaboration with NCCN,” said Victor Lee, MD, director of content development at Zynx Health. “We believe that Zynx OncologyCare chemotherapy order sets will enable oncology practices to streamline order entry workflow and optimize reimbursement potential.” Zynx OncologyCare order sets are based on the NCCN Drugs & Biologics Compendium, which several major payers regard as a primary source for making cancer coverage determinations. By relying on Zynx OncologyCare order sets, clients can be confident about reimbursement.
Zynx OncologyCare directly addresses the complexities of appropriate chemotherapy administration, including:
• Chemotherapy dosing
• Supportive care, such as premedications and antiemetic therapy
• Monitoring and hold parameters, with applicable laboratory orders
• Safety parameters and special instructions
Clients can access the order sets using Zynx’s Web-based software, AuthorSpace™. AuthorSpace streamlines the content management process by enabling clients to access, customize, share, and update order sets. Cancer centers can then deploy the order sets at the point of care, either in paper form or on an intranet, or to an electronic medical record (EMR) system.
“The NCCN Chemotherapy Order Templates, which are the basis for Zynx OncologyCare, can enhance patient safety by helping clinicians standardize patient care, reduce medication errors, and anticipate and manage adverse events,” said William T. McGivney, PhD, chief executive officer of NCCN. “NCCN is pleased to collaborate with Zynx Health on this new product that promotes the safe use of drugs and biologics in cancer care.”
About Zynx Health
Zynx Health was founded in 1996 by thought leaders in evidence-based healthcare and healthcare quality improvement. Acquired by Hearst Corporation in 2004, Zynx has grown to become a recognized leader in evidence-based clinical decision support and offers a suite of online solutions that help clinicians treat their patients based on the best available evidence from systematic research. The Zynx team of physicians, nurses, and allied health professionals rigorously reviews the latest peer-reviewed literature to develop clinically relevant summaries and distill evidence-based best practices. For more information about Zynx Health, visit www.zynxhealth.com
Source: Zynx Health
